Drug intelligence / Profile preview

PADMA 28

Development stage
Phase 2
Lead developer
Padma
Modality
Small Molecules
Administration
Oral
01

Overview

PADMA 28 is a complex herbal preparation based on traditional Tibetan medicine. It contains a blend of approximately 20 different herbs along with calcium sulfate and natural camphor. The formulation is used primarily for the symptomatic treatment of circulatory disorders such as intermittent claudication and peripheral arterial occlusive disease (PAOD). Clinical studies indicate that it may improve walking distance in patients with PAOD and has shown potential benefits in other vascular conditions and chronic inflammatory diseases including recurrent respiratory tract infections, viral hepatitis, multiple sclerosis, polyneuropathy, venous leg complaints, and diabetes-associated paresthesias[1][3][4][7][8]. Mechanistically, PADMA 28 exhibits lipid-lowering activity; inhibits blood lipid oxidizability; increases fibrinolytic activity; inhibits platelet aggregation; modulates neutrophil-derived free radicals; decreases oxidative burst response of monocytes; inhibits cellular response to growth factors involved in atherosclerosis/restenosis; suppresses inflammatory cytokine production; stimulates physiological angiogenesis at low doses[1][6][9]. Its main active constituents are bioflavonoids, tannins, terpenes, essential oils—providing anti-inflammatory, antioxidant/antiperoxidal effects as well as cytoprotective and wound-healing properties[6]. PADMA 28 has been registered as a drug in Switzerland since the late 1970s. It is generally considered safe with mild side effects such as gastrointestinal discomfort or skin eruptions reported at rates similar to placebo[1][3].

Brand names
PADMA 28PADMA28PADMA-28Padma Circosan (in some markets)Padma 28 ActivePadma28 ActivePadma-28 ActivePADMA 28NPADMA28NPADMA-28N
Other names
Tibetan herbal formula for circulatory disordersTibetan multi-compound remedy
02

Targets

PLAU (uPA)

Beyond the preview

Go deeper on PADMA 28.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PADMA 28.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call